Stoppe, Christian
Preiser, Jean-Charles
de Backer, Daniel
Elke, Gunnar
Article History
Received: 11 July 2022
Accepted: 15 July 2022
First Online: 30 July 2022
Declarations
:
: Not applicable.
: All authors confirmed consent on publication of the present manuscript.
: Dr. Stoppe reported that he has received consultant fees from Baxter Healthcare and Fresenius Kabi in the past. Dr. Preiser reported that he has received travel expenses, speaker and advisory honoraria from Baxter, Fresenius Kabi, Nestlé HealthScience and Nutricia Danone. Dr. Elke reported that he has received travel expenses, speaker and advisory honoraria from Fresenius Kabi. Dr. De Backer declares that he has no conflict of interest.